| scholarly article | Q13442814 |
| P2093 | author name string | Hafez M Bazaraa | |
| Soha A Nasr | |||
| Fatina I Fadel | |||
| Hala M Koura | |||
| Eman A Elghoroury | |||
| Manal F Elshamaa | |||
| Mona H Ibrahim | |||
| Doaa M Salah | |||
| Gamila S El-Saaid | |||
| Neemat M A Kassem | |||
| P2860 | cites work | CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 |
| Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs | Q57702564 | ||
| Heightened Peripheral Blood Lymphocyte CD69 Expression is Neither Sensitive nor Specific as a Noninvasive Diagnostic Test for Renal Allograft Rejection | Q59314395 | ||
| The activation antigen CD69 is selectively expressed on CD8+ endomyocardium infiltrating T lymphocytes in human rejecting heart allografts | Q68074718 | ||
| Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation | Q72989725 | ||
| Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance | Q73299841 | ||
| Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection | Q73893083 | ||
| The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 | ||
| Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages | Q77998446 | ||
| CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients | Q79760444 | ||
| Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients | Q79779697 | ||
| From vanilla to 28 flavors: multiple varieties of T regulatory cells | Q80141724 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Immune reconstitution following rabbit antithymocyte globulin. | Q33827314 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Identification of regulatory T cells in tolerated allografts | Q34524237 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Regulatory T cells: potential in organ transplantation | Q35630636 | ||
| Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients | Q35985731 | ||
| Regulatory T cells in immunologic self-tolerance and autoimmune disease | Q36203567 | ||
| Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients | Q36229465 | ||
| Chronic renal allograft dysfunction | Q36240051 | ||
| CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 | ||
| Specific alloantigen self-control by regulatory T cells in organ transplantation: a review | Q36907769 | ||
| Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period | Q37078189 | ||
| Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells | Q37317866 | ||
| FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance | Q37937127 | ||
| Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells | Q38323893 | ||
| Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients | Q40095301 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | Q41908710 | ||
| Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury. | Q42636572 | ||
| CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients | Q44514952 | ||
| Natural history, risk factors, and impact of subclinical rejection in kidney transplantation | Q44997881 | ||
| Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 | ||
| Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients | Q45864185 | ||
| Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients. | Q46005391 | ||
| Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells | Q46739924 | ||
| Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients | Q46763752 | ||
| The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. | Q46894286 | ||
| Regulatory CD25+ T cells in human kidney transplant recipients | Q47895876 | ||
| Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant | Q47989417 | ||
| Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. | Q53557761 | ||
| Diagnostic and predictive value of an immunohistochemical profile in asymptomatic acute rejection of renal allografts. | Q54163100 | ||
| Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. | Q54622675 | ||
| Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy | Q56765660 | ||
| Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin | Q56765727 | ||
| Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin | Q56901703 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 121-130 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | International Journal of Biomedical Science | Q26842285 |
| P1476 | title | Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients | |
| P478 | volume | 11 |
Search more.